Heart Disease Clinical Trials

416 recruitingLast updated: June 17, 2026

There are 416 actively recruiting heart disease clinical trials across 62 countries. Studies span Not Applicable, Phase 4, Phase 2, Phase 3, Phase 1, Early Phase 1. Top locations include New York, New York, United States, Boston, Massachusetts, United States, Rochester, Minnesota, United States. Updated daily from ClinicalTrials.gov.


Heart Disease Trials at a Glance

416 actively recruiting trials for heart disease are listed on ClinicalTrialsFinder across 6 cities in 62 countries. The largest study group is Not Applicable with 158 trials, with the heaviest enrollment activity in New York, Boston, and Rochester. Lead sponsors running heart disease studies include Mayo Clinic, Fundación EPIC, and Boston Children's Hospital.

Browse heart disease trials by phase

Treatments under study

About Heart Disease Clinical Trials

Looking for clinical trials for Heart Disease? There are currently 27 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Heart Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Heart Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 416 trials

Recruiting

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

Coronary Artery DiseaseIschemic Heart Disease
Fundación EPIC500 enrolled12 locationsNCT06863155
Recruiting

Personalized Environment and Genes Study

AsthmaDiabetesHeart Disease
National Institute of Environmental Health Sciences (NIEHS)25,000 enrolled2 locationsNCT00341237
Recruiting

MULTIVALVE : A Prospective Multicentre Study of Multiple and Mixed Valvular Heart Disease

Valvular Heart Disease
French Cardiology Society1,000 enrolled2 locationsNCT07176507
Recruiting
Not Applicable

Effects of Myofascial Release on Cardiac Patients After Median Sternotomy

Coronary Artery Disease (CAD)Valve Heart DiseaseAortic Aneurysm and Dissection
Siou-Pin Huang50 enrolled1 locationNCT07649330
Recruiting
Not Applicable

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Heart FailureCardiovascular DiseasesPulmonary Hypertension+1 more
Abbott Medical Devices850 enrolled68 locationsNCT06526195
Recruiting
Phase 2

Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG

Ischemic Heart Disease
Rohto Pharmaceutical Co., Ltd.50 enrolled1 locationNCT07192211
Recruiting
Phase 2

Transition to KPL-387 Monotherapy Dosing & Administration Study

PericarditisHeart DiseasesRecurrent Pericarditis
Kiniksa Pharmaceuticals International, plc80 enrolled32 locationsNCT07288216
Recruiting
Not Applicable

CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2)

Coronary Heart Disease
Queen Mary University of London1,000 enrolled1 locationNCT07165678
Recruiting
Not Applicable

The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study

Cardiac Magnetic Resonance ImagingIschemic Heart Disease (IHD)Myocardial Blood Flow
Brigham and Women's Hospital1,000 enrolled12 locationsNCT06854458
Recruiting
Not Applicable

Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM)

Blood PressureHeart DiseaseHypertension (HTN)+1 more
Biobeat Technologies Ltd.600 enrolled10 locationsNCT07240831
Recruiting
Phase 1

A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

Premature Coronary Heart DiseaseHeterozygous Familial Hypercholesterolemia
Verve Therapeutics, Inc.85 enrolled23 locationsNCT06164730
Recruiting
Not Applicable

International Multicenter Project Comparing Radiofrequency Ablation Versus Implantable Defibrillator After Well-tolerated Ventricular Tachycardia in Ischemic Heart Disease With Minimally Impaired Ejection Fraction

Ventricular TachycardiaIschemic Heart Disease
University Hospital, Toulouse268 enrolled1 locationNCT06294028
Recruiting

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Heart FailureCardiotoxicityMyocardial Infarction+12 more
Peerbridge Health, Inc2,000 enrolled8 locationsNCT06699056
Recruiting

Multimodal mAgnetic Resonance imaGIng in Cardiovascular Disease

CardiomyopathyCardiovascular DiseasesHeart Valve Diseases+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University2,000 enrolled1 locationNCT07617844
Recruiting

Exercise Echocardiography Registry for Ischemic and Non-Ischemic Heart Disease

Ischemic Heart DieaseNon-ischemic Heart Disease
Yonsei University10,000 enrolled1 locationNCT07367893
Recruiting

Testing VIRTUES Patient Care Sets in Cardiac Patients (VIRTUES Cardiac Care)

Cardiovascular DiseasesAtrial FibrillationArrhythmias, Cardiac+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2,000 enrolled1 locationNCT05452356
Recruiting
Not Applicable

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Ischemic Heart DiseaseST Segment Elevation Myocardial Infarction
Thomas Engstrom150 enrolled1 locationNCT02445885
Recruiting

American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)

Diabetes MellitusCardiovascular DiseasesChronic Kidney Diseases+1 more
University of New Mexico500 enrolled3 locationsNCT04185844
Recruiting
Not Applicable

Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)

Coronary Heart Disease (CHD)
Gan Lijun2,170 enrolled3 locationsNCT07587099
Recruiting
Not Applicable

Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)

Cardiovascular DiseasesMyocardial IschemiaHeart Diseases+3 more
VahatiCor, Inc.30 enrolled2 locationsNCT07449325